naion glp-1 news Popular Type 2 Diabetes Drug Associated with Increased Risk of Andrew Lee, MD | NAION

The level of D-lactate in the portal circulation is elevated in obese individuals and in individuals with type 2 diabetes, whereas the level of L-lactate is unchanged in comparison to lean individuals without type 2 diabetes

Bupropion stimulates the appetite-regulating centres, while naltrexone blocks a feedback loop that would otherwise blunt that effect together reducing hunger and the cravings that drive overeating

Importantly, nodule detection often reflects improved healthcare vigilance rather than drug-induced formation

Doctors or clinics may offer compounded semaglutide with B12 to provide both benefits at once

Sources: Eagleson KL, et al